Plutux
$59.13
+1.03%
N/A+$0.60
Healthcare
Biotechnology
NASDAQ
Active Trading

Exelixis, Inc. operates as a biotechnology firm dedicated to combating cancer, primarily focusing on the identification, advancement, and marketing of novel oncological ...

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

© Plutux Technology Limited 2026
Exelixis, Inc. (EXEL) earnings calendar and key dates